Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-20

Clinical Trial Update: Tirzepatide Use in People With Obesity and Type 1 Diabetes [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update for tirzepatide in people with obesity and Type 1 diabetes, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tirzepatide (tirzepatide)

Snippet

Sponsor: Dasman Diabetes Institute | Conditions: Type1diabetes, Obesity | Phase 4 | Status: RECRUITING